Eberhard Karls Universitt Tbingen Medizinische Fakultt competitive analysis

Latest publications and patents of Eberhard Karls Universitt Tbingen Medizinische Fakultt New

Explore the latest publications and patents granted to Eberhard Karls Universitt Tbingen Medizinische Fakultt, showcasing their recent innovations and technological advancements.

Last updated on: Sep 28, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Eberhard Karls Universitt Tbingen Medizinische Fakultt

Dec 4, 2019Permanent Gene Correction By Means Of Nucleotide-Modified Messenger RnaRevoked
Jan 31, 2018Means And Methods For Ocular Drug DeliveryNo Opposition Filed Within Time Limit
Jan 3, 2018Biomarkers For Type 2 DiabetesNo Opposition Filed Within Time Limit

Explore Eberhard Karls Universitt Tbingen Medizinische Fakultt's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 4, 2019Permanent Gene Correction By Means Of Nucleotide-Modified Messenger Rna1

Latest PTAB cases involving Eberhard Karls Universitt Tbingen Medizinische Fakultt

Discover the latest PTAB cases involving Eberhard Karls Universitt Tbingen Medizinische Fakultt, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Eberhard Karls Universitt Tbingen Medizinische Fakultt with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
EBERHARD KARLS UNIVERSITT TBINGEN MEDIZINISCHE FAKULTT - 1 - - Non-Active
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB33 - - - Highly Aggressive